Developer docs
API playgroundTry for free, no card

Search company profiles

Ourobio

Full company profile

uuid0003d6w

Namestring
Ourobio
Legal namestring
Transfoam LLC
Websiteurl
ourobio.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Ourobio, operating under the legal entity Transfoam LLC, is an early-stage synthetic biology company that engineers microorganisms to convert industrial byproducts into polyhydroxyalkanoates (PHAs) and complementary bio-based additives via fermentation. Its core technological differentiator is the ability of its proprietary microbial strains to co-produce multiple complementary biomaterials simultaneously in a single fermentation run, using waste-based feedstocks such as dairy processing byproducts — thereby reducing both input costs and land/nutrient competition with food production. Founded as an iGEM research project at the University of Virginia in 2019 and spun out in March 2020, the company relocated from Charlottesville, Virginia to a shared lab at the Indiana Bioscience Research Institute in Indianapolis in October 2022.

The company's product portfolio centers on PHA biodegradable plastic resins intended to replace petrochemical plastics in products and packaging, supported by bio-based additives designed to accelerate PHA adoption. Ourobio operates as a B2B biomaterials supplier and technology licensor, monetizing through three stated revenue streams: direct biomaterial sales, licensing of its fermentation technologies, and consulting services such as waste stream analysis and material formulation. Its primary target customers are footwear brands and consumer goods manufacturers seeking sustainable, biodegradable material alternatives, with the company recently demonstrating 3D-printed PHA soles through the Korvaa Consortium at the Future Fabrics Expo 2025 in London.

The company remains in early-stage R&D and prototype demonstration, with disclosed funding of approximately $190,000 across four rounds, 1-10 employees, no disclosed commercial customers, and no published revenue figures. Distribution is conducted through direct B2B outreach via the company website and organic social channels, with strategic partnerships (Ecovative, Modern Synthesis) serving as the primary go-to-market validation mechanism.

Short descriptiontext

Ourobio is an early-stage synthetic biology company that engineers microorganisms to ferment industrial byproducts into biodegradable PHA bioplastics and additives. It serves footwear brands and consumer goods manufacturers seeking sustainable material alternatives through direct B2B sales and technology licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCharlottesville, United States
HQ citystring
Charlottesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biodegradable bioplastics, synthetic biology platform, fermentation biomanufacturing, PHA production, circular economy materials
Industry3 codes
PRIMARYIMANAAAG
Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends)
SECONDARYIMANABAF
Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends)
SECONDARYIMALAMAB
Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films)
NAICS code1 code
  • Petrochemical Manufacturing32511
SIC code1 code
  • Industrial Organic Chemicals2860
Product category
Biodegradable Biomaterials / Bioplastics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Biomaterial Sales
TypeHardware Sales
Description

Sale of bio-based, biodegradable plastic resins and additives produced through fermentation to brands seeking sustainable material alternatives.

ourobio.com
2Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary fermentation technologies to third parties for their own biomanufacturing operations.

ourobio.com
3Consulting Services
TypeProfessional Services
Description

Services including waste stream analysis and product/material formulation to help brands adopt more sustainable materials.

ourobio.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Ourobio develops engineered microorganisms that upcycle industrial byproducts (e.g., dairy processing waste) into polyhydroxyalkanoates (PHAs) — bio-based, biodegradable plastic resins — and complementary bio-based additives through fermentation. Their microbes can co-produce multiple complementary biomaterials simultaneously in a single fermentation run without competing with food production for land or nutrients, and the resulting PHAs can be processed (including via 3D printing) into components such as footwear soles.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Founded as Transfoam in early 2019, spun out in March 2020
+1 more record
Product overview1 text field

Ourobio develops engineered microorganisms to turn industrial byproducts into biomaterials through fermentation. Their product portfolio includes polyhydroxyalkanoates (PHAs) - bio-based, biodegradable plastic resins that replace petroplastics, and complementary bio-based additives that accelerate PHA adoption. Ourobio's unique microbes produce multiple complementary biomaterials simultaneously in a single fermentation process using waste-based feedstocks. Services offered include waste stream analysis, product/material formulation, and licensing of fermentation technologies. The company partnered with the Korvaa Consortium to 3D print soles for concept footwear using PHAs, demonstrating how nature-based materials can replace traditional synthetic components.

Product and service4 records
1Polyhydroxyalkanoates (PHAs)
CategoryBio-based material / Biodegradable plastic resin
Description

A class of bio-based, biodegradable polyesters produced through fermentation using engineered microorganisms and industrial byproducts. PHAs can replace petroplastics in products and packaging and are sold as a resin to brands seeking sustainable material alternatives.

2Bio-based additives
CategoryAdditive / Formulation component
Description

Bio-based additives designed to accelerate PHA adoption and enhance material properties for various applications. Sold as formulation components to manufacturers.

3Korvaa concept footwear - PHA sole
CategoryProduct component / 3D printed biomaterial
Description

3D printed sole using polyhydroxyalkanoates (PHAs), produced as part of the Korvaa Consortium's collaborative concept footwear project demonstrating nature-based material alternatives to traditional synthetics.

4Waste stream analysis and material formulation consulting
CategoryProfessional services / Consulting
Description

Consulting services including waste stream analysis and product/material formulation to help brands adopt more sustainable materials.

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

Modern Synthesis supplied bacterial nanocellulose upper for the Korvaa concept footwear - a three-way biomaterial collaboration demonstrating nature-based materials replacing traditional synthetic components.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

Ecovative grew mycelium in the sole of the Korvaa concept footwear over seven days as part of the biomaterial collaboration. Ecovative specializes in mycelium-based materials.

3Transfoam
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

Ourobio originated from Transfoam, which began as an iGEM research project at the University of Virginia in early 2019. Transfoam represents Ourobio's predecessor and continuing identity in the synthetic biology community.

designboom.com
4Korvaa Consortium
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-24
Description

The Korvaa Consortium unveiled concept footwear at the Future Fabrics Expo 2025 in London. Ourobio 3D printed the sole using polyhydroxyalkanoates as part of this collaborative effort demonstrating bio-based materials in footwear applications.

designboom.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ourobio

Biodegradable Biomaterials / Bioplasticsourobio.com

Ourobio is an early-stage synthetic biology company that engineers microorganisms to ferment industrial byproducts into biodegradable PHA bioplastics and additives. It serves footwear brands and consumer goods manufacturers seeking sustainable material alternatives through direct B2B sales and technology licensing.

What Ourobio does

Ourobio, operating under the legal entity Transfoam LLC, is an early-stage synthetic biology company that engineers microorganisms to convert industrial byproducts into polyhydroxyalkanoates (PHAs) and complementary bio-based additives via fermentation. Its core technological differentiator is the ability of its proprietary microbial strains to co-produce multiple complementary biomaterials simultaneously in a single fermentation run, using waste-based feedstocks such as dairy processing byproducts — thereby reducing both input costs and land/nutrient competition with food production. Founded as an iGEM research project at the University of Virginia in 2019 and spun out in March 2020, the company relocated from Charlottesville, Virginia to a shared lab at the Indiana Bioscience Research Institute in Indianapolis in October 2022.

The company's product portfolio centers on PHA biodegradable plastic resins intended to replace petrochemical plastics in products and packaging, supported by bio-based additives designed to accelerate PHA adoption. Ourobio operates as a B2B biomaterials supplier and technology licensor, monetizing through three stated revenue streams: direct biomaterial sales, licensing of its fermentation technologies, and consulting services such as waste stream analysis and material formulation. Its primary target customers are footwear brands and consumer goods manufacturers seeking sustainable, biodegradable material alternatives, with the company recently demonstrating 3D-printed PHA soles through the Korvaa Consortium at the Future Fabrics Expo 2025 in London.

The company remains in early-stage R&D and prototype demonstration, with disclosed funding of approximately $190,000 across four rounds, 1-10 employees, no disclosed commercial customers, and no published revenue figures. Distribution is conducted through direct B2B outreach via the company website and organic social channels, with strategic partnerships (Ecovative, Modern Synthesis) serving as the primary go-to-market validation mechanism.

Ourobio firmographics

Firmographics
Name
Ourobio
Legal name
Transfoam LLC
Website
https://ourobio.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Ourobio is an early-stage synthetic biology company that engineers microorganisms to ferment industrial byproducts into biodegradable PHA bioplastics and additives. It serves footwear brands and consumer goods manufacturers seeking sustainable material alternatives through direct B2B sales and technology licensing.
Ownership category
akta.pro rank

Ourobio industry classification

Industry
Product category
Biodegradable Biomaterials / Bioplastics
NAICS
Petrochemical Manufacturing (32511)
SIC
Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYIMANAAAG
Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends)
SECONDARYIMANABAF
Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends)
SECONDARYIMALAMAB
Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films)

Keywords

  • Biodegradable bioplastics
  • Synthetic biology platform
  • Fermentation biomanufacturing
  • PHA production
  • Circular economy materials

Where Ourobio is headquartered

Location

Headquarters

HQ city
Charlottesville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Ourobio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Biomaterial Sales: Sale of bio-based, biodegradable plastic resins and additives produced through fermentation to brands seeking sustainable material alternatives.
  2. Technology Licensing: Licensing of proprietary fermentation technologies to third parties for their own biomanufacturing operations.
  3. Consulting Services: Services including waste stream analysis and product/material formulation to help brands adopt more sustainable materials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Ourobio product offering

Product offering

Core offering

Ourobio develops engineered microorganisms that upcycle industrial byproducts (e.g., dairy processing waste) into polyhydroxyalkanoates (PHAs) — bio-based, biodegradable plastic resins — and complementary bio-based additives through fermentation. Their microbes can co-produce multiple complementary biomaterials simultaneously in a single fermentation run without competing with food production for land or nutrients, and the resulting PHAs can be processed (including via 3D printing) into components such as footwear soles.

Product overview

Ourobio develops engineered microorganisms to turn industrial byproducts into biomaterials through fermentation. Their product portfolio includes polyhydroxyalkanoates (PHAs) - bio-based, biodegradable plastic resins that replace petroplastics, and complementary bio-based additives that accelerate PHA adoption. Ourobio's unique microbes produce multiple complementary biomaterials simultaneously in a single fermentation process using waste-based feedstocks. Services offered include waste stream analysis, product/material formulation, and licensing of fermentation technologies. The company partnered with the Korvaa Consortium to 3D print soles for concept footwear using PHAs, demonstrating how nature-based materials can replace traditional synthetic components.

Differentiator

Problem solved

Functional benefit

Products and services

  • Polyhydroxyalkanoates (PHAs) A class of bio-based, biodegradable polyesters produced through fermentation using engineered microorganisms and industrial byproducts. PHAs can replace petroplastics in products and packaging and are sold as a resin to brands seeking sustainable material alternatives.
  • Bio-based additives Bio-based additives designed to accelerate PHA adoption and enhance material properties for various applications. Sold as formulation components to manufacturers.
  • Korvaa concept footwear - PHA sole 3D printed sole using polyhydroxyalkanoates (PHAs), produced as part of the Korvaa Consortium's collaborative concept footwear project demonstrating nature-based material alternatives to traditional synthetics.
  • Waste stream analysis and material formulation consulting Consulting services including waste stream analysis and product/material formulation to help brands adopt more sustainable materials.

Quantifiable outcome

  • Founded as Transfoam in early 2019, spun out in March 2020
  • +1 more outcomes

Companies that use Ourobio

Customer profile

Segments2 records

Ideal customer profiles2 records

Ourobio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Ourobio partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Modern SynthesiscoreStrategic or Co-development Partner · 24 June 2025Modern Synthesis supplied bacterial nanocellulose upper for the Korvaa concept footwear - a three-way biomaterial collaboration demonstrating nature-based materials replacing traditional synthetic components.
  • EcovativecoreStrategic or Co-development Partner · 24 June 2025Ecovative grew mycelium in the sole of the Korvaa concept footwear over seven days as part of the biomaterial collaboration. Ecovative specializes in mycelium-based materials.
  • TransfoamcoreStrategic or Co-development Partner · 24 June 2025Ourobio originated from Transfoam, which began as an iGEM research project at the University of Virginia in early 2019. Transfoam represents Ourobio's predecessor and continuing identity in the synthetic biology community.
  • Korvaa ConsortiumcoreStrategic or Co-development Partner · 24 June 2025The Korvaa Consortium unveiled concept footwear at the Future Fabrics Expo 2025 in London. Ourobio 3D printed the sole using polyhydroxyalkanoates as part of this collaborative effort demonstrating bio-based materials in footwear applications.

Recent moves9 records

Expansion highlights5 records

Ourobio competitors and assessment

Company assessment

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Customer concentration

Ourobio social profiles

Digital presence

Ourobio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ourobio leadership team

Management profile

Number of profiles

Profiles2 records

Ourobio funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ourobio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ourobio

What does Ourobio do?

Ourobio develops engineered microorganisms that upcycle industrial byproducts (e.g., dairy processing waste) into polyhydroxyalkanoates (PHAs) — bio-based, biodegradable plastic resins — and complementary bio-based additives through fermentation. Their microbes can co-produce multiple complementary biomaterials simultaneously in a single fermentation run without competing with food production for land or nutrients, and the resulting PHAs can be processed (including via 3D printing) into components such as footwear soles.

Is Ourobio a public or private company?

Ourobio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Ourobio founded?

Ourobio was founded in 2019. It employs 1 to 10 people.

Where is Ourobio based?

Ourobio is headquartered in Charlottesville, United States, in the North America region.

How does Ourobio make money?

Three revenue lines are on record. Biomaterial Sales are the primary driver. The others are technology Licensing and consulting Services.

Does Ourobio have an API?

No public API is recorded for Ourobio.

What industry is Ourobio in?

Ourobio's product category is Biodegradable Biomaterials / Bioplastics. Its primary akta.pro industry code is IMANAAAG, Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends), with a secondary code of IMANABAF, Bio-Based & Biodegradable Compounds (PLA/PHA/Starch Blends). Its NAICS code is 32511 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ForbesCould Cheese Waste Be The Solution To The Plastic Packaging Crisis?Ourobio, a startup founded by Alec Brewer, produces compostable plastics from cheese whey, co-producing PHAs and pigments. The company aims to scale production, with early markets including petcare and fashion. It expects regulatory shifts and policy support to accelerate adoption.designboomkorvaa shoes come to life using mycelium, bacterial nanocellulose and biodegradable plasticsThe Korvaa Consortium unveiled concept footwear made from mycelium, bacterial nanocellulose, and biodegradable plastics at the Future Fabrics Expo 2025 in London on June 24–25. The shoe is a three-way biomaterial collaboration: Modern Synthesis supplied the bacterial nanocellulose upper, Ourobio 3D printed the sole using polyhydroxyalkanoates, and Ecovation grew mycelium in the sole over seven days. The concept footwear demonstrates how nature-based materials can replace traditional synthetic components, with a documentary titled "Planet of the Microbes" also documenting the production process.Inside Indiana BusinessInnovation Showcase awards life science, digital startups – Inside INdiana BusinessFive Indiana-based startups received cash prizes for their innovative contributions at the Venture Club of Indiana’s Innovation Showcase held in Indianapolis on Thursday. The first place winners in the Life Sciences/AgTech category were FiberX, claiming $10,000, while OuroBio secured second place with a $5,000 prize. In the Digital Innovation category, StoryBolt took first place, with two additional winners for second place yet to be named.VabioOurobio takes top honors at Lighthouse Labs Demo DayOurobio, a Charlottesville-based startup developing bio-based polymers from industrial waste, won the top prize at the Lighthouse Labs Demo Day. The company received a $1,500 cash award for its pitch, which was praised by judges for its clear market strategy and technical viability. This victory marks a significant milestone for the pre-revenue, bootstrapped firm as it seeks to scale its marine sustainability solutions.American City Business JournalsOurobio takes top honors at Lighthouse Labs Demo DayOurobio won the $1,500 cash prize at the Lighthouse Labs Demo Day held at the Byrd Theatre in Richmond on May 26, 2022. Co-founder and CEO Alec Brewer stated that the funding is critical for the bootstrapped company. The event served as a 'Shark Tank'-style competition for local startups.